Skip to content

Analysis of curative effect of traditional Chinese medicine on patients with non-small cell lung cancer after radical surgery: a retrospective cohort study

Analysis of curative effect of traditional Chinese medicine on patients with non-small cell lung cancer after radical surgery: a retrospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071075
Enrollment
Unknown
Registered
2023-05-04
Start date
2023-05-04
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small-cell lung cancer

Interventions

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Postoperative patients diagnosed with primary bronchogenic carcinoma and pathologically confirmed as NSCLC; (2) The pathology of NSCLC includes adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, large cell carcinoma, etc; (3) Individuals over 18 years old; (4) Chinese medicine treatment (including Chinese herbal pieces and traditional Chinese patent medicines and simple preparations) that has been carried out continuously for 6 months or more; (5) Postoperative adjuvant treatment or follow-up without any traditional Chinese medicine treatment (including Chinese medicine decoction pieces and traditional Chinese patent medicines and simple preparations); (6) Hospitalized or outpatient patients with complete information; (7) During the follow-up process, there are detailed medical records and clear dates of recurrence, death, etc.

Exclusion criteria

Exclusion criteria: (1) Primary lung cancer with unclear pathological type, or with clear pathological type but not classified as non-small cell lung cancer; (2) Patients with unclear clinical staging after NSCLC radical surgery; (3) Individuals with other primary malignant tumors at the same time; (4) Have a history of organ transplantation; (5) Having severe chronic diseases; (6) Having a history of uncontrollable mental illness; (7) Children's cases, those who are currently pregnant or breastfeeding; (8) Intermittent traditional Chinese medicine intervention with a total course of treatment less than 6 months; (9) Patients with incomplete data that cannot be evaluated and followed up.

Design outcomes

Primary

MeasureTime frame
Overall survival rate(1 year,2 years and years);

Secondary

MeasureTime frame
Overall survival, OS;Disease-free survival, DFS;Disease free survival;

Countries

China

Contacts

Public ContactZhang Sufang

Shanghai Pulmonary Hospital

13818240751@163.com+86 13585605365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026